![Mohamed Shoreibah](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Dr. Mohamed Shoreibah is Research Director at Abeome Corp.
He received his doctorate degree from the University of Miami (Florida).
Eerdere bekende functies van Mohamed Shoreibah
Bedrijven | Functie | Einde |
---|---|---|
Abeome Corp.
![]() Abeome Corp. BiotechnologyHealth Technology Abeome Corp. operates as a biotechnology company. It develops therapeutic and diagnostic monoclonal antibodies (mAbs). The firm’s DiSH (Direct Selection of Hybridomas) technology offers a process for selecting and cloning desired hybridomas that produce antibodies with optimal binding characteristics. The company was founded by Richard B. Meagher in 2000 and is headquartered in Athens, GA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Mohamed Shoreibah
University of Miami | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Abeome Corp.
![]() Abeome Corp. BiotechnologyHealth Technology Abeome Corp. operates as a biotechnology company. It develops therapeutic and diagnostic monoclonal antibodies (mAbs). The firm’s DiSH (Direct Selection of Hybridomas) technology offers a process for selecting and cloning desired hybridomas that produce antibodies with optimal binding characteristics. The company was founded by Richard B. Meagher in 2000 and is headquartered in Athens, GA. | Health Technology |